Immunosuppression: Clinical Trials

158 trials for Immunosuppression, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

77 completed, 33 unknown, 18 recruiting, 12 terminated. 35 Phase 4, 28 Not applicable, 21 Phase 2, 11 Phase 1, 10 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 435Completed 12, Unknown 10, Recruiting 5, Active not recruiting 4, Terminated 3, Not yet recruiting 1
Not applicable28Completed 16, Recruiting 3, Unknown 3, Not yet recruiting 2, Terminated 2, Suspended 1, Withdrawn 1
Phase 221Completed 10, Unknown 4, Not yet recruiting 3, Recruiting 2, Terminated 1, Withdrawn 1
Phase 111Completed 8, Terminated 2, Unknown 1
Phase 310Completed 5, Unknown 3, Recruiting 1, Withdrawn 1
Early Phase 12Completed 2

Follow Immunosuppression: new trials by email Literature Review of Immunosuppression trials Research Report on Immunosuppression

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
(TNX-1500) in Kidney Transplant Recipients
TNX-1500, Kidney Transplant - Kidney Transplant, Kidney Transplant Failure and Rejection
Phase 2Not yet recruitingAyman Al Jurdi, MD52026-11-012026-08-19
Thymalfasin for Immune Recovery in Adults With Sepsis
Thymalfasin (Thymosin alpha 1, Ta1) - Sepsis, Immunosuppression
Not applicableRecruitingShanghai Zhongshan Hospital602026-10-062026-10-08
NAI for Sepsis With Persistent Lymphopenia
Nogapendekin alfa inbakicept (NAI), Standard of Care (SOC) - Sepsis, Septic Shock
Phase 2Not yet recruitingImmunityBio, Inc.502026-07-062026-05-11
Metabolic and Functional Study of γδ T Cells in Critically Ill Patients
Sepsis, Critical Illness
RecruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology1052026-06-212026-10-27
Adaptation of Lung Transplant Recipients at Extreme Altitude
Lung Transplantation, Hypoxia
Active not recruitingMedical University of Vienna302026-01-102026-03-18
Evaluation of PCV21 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans
21-valent pneumococcal conjugate vaccine - Pneumococcal Vaccines, Immunosuppression
Phase 4Not yet recruitingVA Sierra Nevada Health Care System452026-01-012025-08-14
HeartCare Immuno-optimization in Cardiac Allografts (MOSAIC)
HeartCare - Heart Transplant, Immunosuppression
Not applicableNot yet recruitingCareDx9302025-12-012024-10-23
Fibroscan to Guide Post Transplant Immunosuppression Minimization
Immunosuppression reduction - Immunosuppression
Not applicableRecruitingUniversity of Alberta502025-12-012026-01-08
Role of MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC
Tumor samples - Lung Neoplasms, Myeloid-Derived Suppressor Cells
Not yet recruitingUniversity Hospital, Bordeaux102025-12-012025-07-30
Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus
Tacrolimus - Kidney Disease, Chronic, Transplant Recipient (Kidney)
Phase 4RecruitingInstituto de Investigación Hospital Universitario La Paz1142025-06-022025-09-11
B-cell Depletion in Offspring to Women With MS Under Immunomodulatory Treatment
Anti-CD20 Monoclonal Antibody - Multiple Sclerosis, B-Cell Deficiency
UnknownRegion Stockholm1112025-06-012024-12-02
Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY)
XR-tacrolimus QD + MMF BID then MMF QD, XR-tacrolimus QD + MMF BID, LCP-tacrolimus QD + MMF QD then MMF QD - Liver Transplantation, Immunosuppression
Phase 4RecruitingUniversity Hospital, Limoges1622025-04-152026-03-19
Effect of Cognitive Therapy on Immunosuppressive Treatment Compliance and Motivation
Intervention group - Liver Transplant; Complications, Immunosuppression
Not applicableCompletedBitlis Eren University1402025-02-152026-02-25
Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS
Single high dose of liposomal amphotericin B, L-AmB standard dose - Disseminated Histoplasma Capsulatum Infection, AIDS and Infections
Phase 3RecruitingFederal University of Health Science of Porto Alegre2792025-01-162026-07-27
Comparability of Fingerprick vs Venous Blood for Tacrolimus Monitoring
Mitra Microsampling Device - Immunosuppression
CompletedNottingham University Hospitals NHS Trust562025-01-072025-06-24
Registry of Vaccine Responses in Immune Compromised Patients
Collection of data in a registry - Immunosuppression
RecruitingLaure Pittet, MD-PhD3002024-09-242024-11-07
Histamine Dihydrochloride and Interleukin-2 in Primary Resectable Pancreatic Cancer
Histamine Dihydrochloride (HDC), Interleukin-2 (IL-2) - Pancreatic Cancer, Surgery
Phase 2Not yet recruitingSahlgrenska University Hospital502024-04-012023-11-22
Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients
Recombinant zoster vaccine adjuvanted (SHINGRIX) - Immunosuppression, Vaccine Response Impaired
Not applicableRecruitingCentral Adelaide Local Health Network Incorporated1602024-03-202026-04-09
Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs
Tacrolimus Pill, Tacrolimus capsule - Immunosuppression
Phase 4RecruitingEdward Geissler3002024-03-092024-05-16
Efficacy and Safety of Immunosuppressive Withdrawal After Pediatric Liver Transplantation
Tacrolimus or Cyclosporine A - Immune Tolerance, Immunosuppression
Not applicableNot yet recruitingWei Gao472023-12-012023-11-27

Showing 20 of 158. Sign in to see all of them.

Narrower conditions

COVID-19 (9)  ·  Rejection, Psychology (8)  ·  Neoplasms (7)  ·  Sepsis (7)  ·  Infections (5)  ·  Renal Insufficiency (5)  ·  Acquired Immunodeficiency Syndrome (3)  ·  Cardiovascular Diseases (3)  ·  Influenza, Human (3)  ·  Kidney Failure, Chronic (3)  ·  Arthritis, Rheumatoid (2)  ·  Carcinoma, Hepatocellular (2)  ·  Cardiomyopathies (2)  ·  Chickenpox (2)  ·  Critical Illness (2)

Broader conditions

Infections (27)  ·  Pathological Conditions, Signs and Symptoms (26)  ·  Immune System Diseases (19)  ·  Pathologic Processes (19)  ·  Virus Diseases (19)  ·  Respiratory Tract Diseases (18)  ·  RNA Virus Infections (16)  ·  Urogenital Diseases (16)  ·  Lung Diseases (14)  ·  Respiratory Tract Infections (12)  ·  Disease Attributes (11)  ·  Female Urogenital Diseases (11)  ·  Female Urogenital Diseases and Pregnancy Complications (11)  ·  Male Urogenital Diseases (11)  ·  Urologic Diseases (11)

Interventions

Tacrolimus (29)  ·  Mycophenolic Acid (18)  ·  Cyclosporine (10)  ·  Sirolimus (10)  ·  Everolimus (8)  ·  Prednisone (5)  ·  Antilymphocyte Serum (4)  ·  Methylprednisolone (4)  ·  thymoglobulin (4)  ·  Abatacept (3)  ·  Adrenal Cortex Hormones (2)  ·  Alemtuzumab (2)  ·  Azathioprine (2)  ·  Blood Specimen Collection (2)  ·  Calcineurin Inhibitors (2)

Sponsors

Emory University (3)  ·  National Eye Institute (NEI) (3)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (3)  ·  Northwestern University (3)  ·  University Medical Center Groningen (3)  ·  University of Florida (3)  ·  CareDx (2)  ·  Changhai Hospital (2)  ·  Heidelberg University (2)  ·  Insel Gruppe AG, University Hospital Bern (2)  ·  Medical University of South Carolina (2)  ·  Medical University of Vienna (2)  ·  Medical University of Warsaw (2)  ·  National Heart, Lung, and Blood Institute (NHLBI) (2)  ·  National Taiwan University Hospital (2)

Countries

United States (49)  ·  China (13)  ·  Canada (12)  ·  Germany (12)  ·  France (8)  ·  Switzerland (8)  ·  Brazil (6)  ·  Italy (5)  ·  United Kingdom (5)  ·  Belgium (4)  ·  Netherlands (4)  ·  Poland (4)  ·  Spain (4)  ·  Austria (3)  ·  Taiwan (3)

Top investigators

Christian P. Larsen, MD, DPhil (2)  ·  Dieter Buchheidt, MD (2)  ·  Michael E de Vera, MD (2)  ·  Upton Allen (2)  ·  Upton Allen, MD (2)  ·  Werner Siegmund, Prof (2)  ·  A. John Barrett, M.D. (1)  ·  Ahmed Shoker, MD (1)  ·  Aiko De Vries, MD, PhD (1)  ·  Alexandra Ershova, PhD (1)  ·  Alexandre Loupy, MD, PhD (1)  ·  Ali Zarrinpar, MD, PhD (1)  ·  Allan Glanville, MD, PhD (1)

Results publications

PMID 10028970, PMID 10030657, PMID 10199738, PMID 10213344, PMID 10221490, PMID 10459544, PMID 10556226, PMID 10594802, PMID 10598732, PMID 10798738, PMID 10802712, PMID 10830164, PMID 10952828, PMID 11055975, PMID 11057898, PMID 11250334, PMID 11514367, PMID 11803349, PMID 12088775, PMID 12438948, PMID 12555153, PMID 12652219, PMID 12668503, PMID 12714020, PMID 12738602, PMID 12742978, PMID 12761269, PMID 12906982, PMID 12962864, PMID 1423934, PMID 14612424, PMID 14757690, PMID 14996650, PMID 15226426, PMID 15239621, PMID 15302787, PMID 15385655, PMID 15543153, PMID 15557389, PMID 15660173, PMID 15899725, PMID 16163382, PMID 16199143, PMID 16282187, PMID 16297769, PMID 16297770, PMID 16297806, PMID 16364861, PMID 16611334, PMID 16642009

NIH funding

2023 (2), 2004 (1), 2009 (1), P30CA014089 (1), P30CA082103 (1), R01DK025243 (1), R21HD106103 (1), R35GM140806 (1), RM1GM139690 (1), U01AI100807 (1)